KLOW is the more relevant blend for reactive or rosacea-prone skin
A "Strong" rating indicates support from multiple well-designed trials, "Moderate" suggests promising but less consistent findings, and "Limited" or "Emerging" applies to areas with early-stage, small, or mixed research
(1997, Journal of Endocrinology) reported that IGF-1 LR3 supported protein turnover in tumor-bearing catabolic rats but also increased tumor growth in that model
The following are its benefits
Visible results are usually seen within six to eight weeks after treatment
GHK-Cu is primarily studied for skin regeneration, wound healing, collagen stimulation, anti-inflammatory signaling, antioxidant defense, hair follicle health, and broad gene expression modulation